[시장보고서]세계의 위식도역류질환(GERD) 시장(2024-2028년)

세계의 위식도역류질환(GERD) 시장(2024-2028년)

Global gastroesophageal reflux disease (GERD) market 2024-2028

상품코드 : 1502325 해당 상품은 즉시 배송 가능합니다

리서치사 : TechNavio

발행일 : 2024년 05월

페이지 정보 : 영문 176 Pages

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Technavio는 위식도역류질환(GERD) 시장이 2023년부터 2028년까지 8억 7,980만 달러, 예측 기간 동안 3.2%의 CAGR로 성장할 것으로 예상하고 있습니다.

위식도역류질환(GERD) 시장에 대해 조사분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 노인 인구의 증가, 생활 패턴의 변화, 의약품 및 건강 보조 식품의 과다 사용 등이 시장을 주도하고 있습니다.

시장 범위
기준 연도	2024
종료 연도	2028
예측 기간	2024-2028
성장 모멘텀	가속
전년 대비 2024년	3.06%
CAGR	3.2%
증분 금액	8억 7,980만 달러

이 보고서는 향후 몇 년간 위식도역류질환(GERD) 시장 성장을 주도할 주요 요인 중 하나로 비만율 증가를 꼽았습니다. 또한, E-Commerce 시장의 확대와 GERD에 대한 인식의 증가도 시장 수요를 견인하는 요인으로 꼽힙니다.

지역별 세분화
지역별 비교
북미 : 시장 규모와 예측 2023-2028
유럽 : 시장 규모와 예측 2023-2028
아시아 : 시장 규모와 예측 2023-2028
세계 기타 지역 : 시장 규모와 예측 2023-2028
미국 : 시장 규모와 예측 2023-2028
독일 : 시장 규모와 예측 2023-2028
영국 : 시장 규모와 예측 2023-2028
중국 : 시장 규모와 예측 2023-2028
캐나다 : 시장 규모와 예측 2023-2028
시장 기회 : 지역별

제10장 촉진요인, 과제, 기회, 억제요인

시장 성장 촉진요인
시장 과제
성장 촉진요인과 과제의 영향
시장 기회·억제요인

제11장 경쟁 상황

개요
경쟁 상황
혼란 상황
업계 리스크

제12장 경쟁 분석

기업 개요
기업의 시장 포지셔닝
Abbott Laboratories
Alkem Laboratories Ltd.
Apotex Inc.
AstraZeneca Plc
Aurobindo Pharma Ltd.
Bayer AG
Cipla Inc.
Dr Reddys Laboratories Ltd.
Eisai Co. Ltd.
Fresenius SE and Co. KGaA
GlaxoSmithKline Plc
inovapharma.com
Johnson and Johnson Services Inc.
Lupin Ltd.
Perrigo Co. Plc

제13장 부록

ksm

영문 목차

영문목차

Technavio has been monitoring the gastroesophageal reflux disease (GERD) market and is forecast to grow by USD 879.8 mn during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. Our report on the gastroesophageal reflux disease (GERD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population, poor lifestyle patterns, and overuse of medicines and dietary supplements.

Technavio's gastroesophageal reflux disease (GERD) market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	3.06%
CAGR	3.2%
Incremental Value	$879.8mn

By Route Of Administration

Oral
Parenteral

By Type

Antacid
PPI
H2 receptor antagonist drugs
Pro-Kinetic drugs

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising prevalence of obesity as one of the prime reasons driving the gastroesophageal reflux disease (GERD) market growth during the next few years. Also, growing e-commerce market and increasing awareness of GERD will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gastroesophageal reflux disease (GERD) market covers the following areas:

Gastroesophageal reflux disease (GERD) market sizing
Gastroesophageal reflux disease (GERD) market forecast
Gastroesophageal reflux disease (GERD) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastroesophageal reflux disease (GERD) market vendors that include Abbott Laboratories, Alkem Laboratories Ltd., Apotex Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, inovapharma.com, Johnson and Johnson Services Inc., Lupin Ltd., Perrigo Co. Plc, Pfizer Inc., SRS Life Sciences Pte. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and The Procter and Gamble Co.. Also, the gastroesophageal reflux disease (GERD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022
- Historic Market Size - Data Table on Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

6.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Parenteral - Market size and forecast 2023-2028
- Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
- Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
- Chart on Parenteral - Year-over-year growth 2023-2028 (%)
- Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
7.3 Antacid - Market size and forecast 2023-2028
- Chart on Antacid - Market size and forecast 2023-2028 ($ million)
- Data Table on Antacid - Market size and forecast 2023-2028 ($ million)
- Chart on Antacid - Year-over-year growth 2023-2028 (%)
- Data Table on Antacid - Year-over-year growth 2023-2028 (%)
7.4 PPI - Market size and forecast 2023-2028
- Chart on PPI - Market size and forecast 2023-2028 ($ million)
- Data Table on PPI - Market size and forecast 2023-2028 ($ million)
- Chart on PPI - Year-over-year growth 2023-2028 (%)
- Data Table on PPI - Year-over-year growth 2023-2028 (%)
7.5 H2 receptor antagonist drugs - Market size and forecast 2023-2028
- Chart on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
- Chart on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
- Data Table on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
7.6 Prokinetic drugs - Market size and forecast 2023-2028
- Chart on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape2023-2028 (%)
- Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
- Market opportunity By Geographical Landscape($ million)
- Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
12.4 Alkem Laboratories Ltd.
- Alkem Laboratories Ltd. - Overview
- Alkem Laboratories Ltd. - Business segments
- Alkem Laboratories Ltd. - Key offerings
- Alkem Laboratories Ltd. - Segment focus
12.5 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
12.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
12.7 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
12.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
12.9 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
12.10 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
12.11 Eisai Co. Ltd.
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
12.12 Fresenius SE and Co. KGaA
- Fresenius SE and Co. KGaA - Overview
- Fresenius SE and Co. KGaA - Business segments
- Fresenius SE and Co. KGaA - Key news
- Fresenius SE and Co. KGaA - Key offerings
- Fresenius SE and Co. KGaA - Segment focus
12.13 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.14 inovapharma.com
- inovapharma.com - Overview
- inovapharma.com - Product / Service
- inovapharma.com - Key offerings
12.15 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
12.16 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Product / Service
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
12.17 Perrigo Co. Plc
- Perrigo Co. Plc - Overview
- Perrigo Co. Plc - Business segments
- Perrigo Co. Plc - Key offerings
- Perrigo Co. Plc - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

한글목차

목차

제1장 주요 요약

제2장 시장 상황

제3장 시장 규모 평가

제4장 시장 규모 실적

제5장 Five Forces 분석

제6장 시장 세분화 : 투여 경로별

제7장 시장 세분화 : 유형별

제8장 고객 상황

제9장 지역별 상황